These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

386 related articles for article (PubMed ID: 24699378)

  • 21. Longdan Xiegan Decoction alleviates experimental autoimmune uveitis in rats by inhibiting Notch signaling pathway activation and Th17 cell differentiation.
    Yin X; Qiu Y; Li Z; Guo L; Wei H; Liu B; Zhou M; Li T; Wang L; Jiang W; Bi H; Guo D
    Biomed Pharmacother; 2021 Apr; 136():111291. PubMed ID: 33493870
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Crucial role of P2X
    Takeda A; Yamada H; Hasegawa E; Arima M; Notomi S; Myojin S; Yoshimura T; Hisatomi T; Enaida H; Yanai R; Kimura K; Ishibashi T; Sonoda KH
    Jpn J Ophthalmol; 2018 May; 62(3):398-406. PubMed ID: 29572578
    [TBL] [Abstract][Full Text] [Related]  

  • 23. IL-33 attenuates the development of experimental autoimmune uveitis.
    Barbour M; Allan D; Xu H; Pei C; Chen M; Niedbala W; Fukada SY; Besnard AG; Alves-Filho JC; Tong X; Forrester JV; Liew FY; Jiang HR
    Eur J Immunol; 2014 Nov; 44(11):3320-9. PubMed ID: 25116404
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Blockade of interleukin-6 signaling suppresses not only th17 but also interphotoreceptor retinoid binding protein-specific Th1 by promoting regulatory T cells in experimental autoimmune uveoretinitis.
    Haruta H; Ohguro N; Fujimoto M; Hohki S; Terabe F; Serada S; Nomura S; Nishida K; Kishimoto T; Naka T
    Invest Ophthalmol Vis Sci; 2011 May; 52(6):3264-71. PubMed ID: 21330657
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Suppression of the Reactive Oxygen Response Alleviates Experimental Autoimmune Uveitis in Mice.
    Hsu SM; Yang CH; Teng YT; Tsai HY; Lin CY; Lin CJ; Shieh CC; Chen SH
    Int J Mol Sci; 2020 May; 21(9):. PubMed ID: 32380695
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Regulation of experimental autoimmune uveoretinitis by anti-delta-like ligand 4 monoclonal antibody.
    Ishida W; Fukuda K; Sakamoto S; Koyama N; Koyanagi A; Yagita H; Fukushima A
    Invest Ophthalmol Vis Sci; 2011 Oct; 52(11):8224-30. PubMed ID: 21896864
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Injection of an alpha-melanocyte stimulating hormone expression plasmid is effective in suppressing experimental autoimmune uveitis.
    Lee DJ; Biros DJ; Taylor AW
    Int Immunopharmacol; 2009 Aug; 9(9):1079-86. PubMed ID: 19426838
    [TBL] [Abstract][Full Text] [Related]  

  • 28. IL-18 not required for IRBP peptide-induced EAU: studies in gene-deficient mice.
    Jiang HR; Wei X; Niedbala W; Lumsden L; Liew FY; Forrester JV
    Invest Ophthalmol Vis Sci; 2001 Jan; 42(1):177-82. PubMed ID: 11133864
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Aminoimidazole carboxamide ribonucleotide ameliorates experimental autoimmune uveitis.
    Suzuki J; Yoshimura T; Simeonova M; Takeuchi K; Murakami Y; Morizane Y; Miller JW; Sobrin L; Vavvas DG
    Invest Ophthalmol Vis Sci; 2012 Jun; 53(7):4158-69. PubMed ID: 22562518
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Therapeutic effect of the potent IL-12/IL-23 inhibitor STA-5326 on experimental autoimmune uveoretinitis.
    Keino H; Watanabe T; Sato Y; Niikura M; Wada Y; Okada AA
    Arthritis Res Ther; 2008; 10(5):R122. PubMed ID: 18847496
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pathogenic Function of Herpesvirus Entry Mediator in Experimental Autoimmune Uveitis by Induction of Th1- and Th17-Type T Cell Responses.
    Sakoda Y; Nagai T; Murata S; Mizuno Y; Kurosawa H; Shoda H; Morishige N; Yanai R; Sonoda KH; Tamada K
    J Immunol; 2016 Apr; 196(7):2947-54. PubMed ID: 26912321
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Activation of OX40 prolongs and exacerbates autoimmune experimental uveitis.
    Wu X; Rosenbaum JT; Adamus G; Zhang GL; Duan J; Weinberg A; Zhang Z
    Invest Ophthalmol Vis Sci; 2011 Oct; 52(11):8520-6. PubMed ID: 21948545
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tofacitinib inhibits the development of experimental autoimmune uveitis and reduces the proportions of Th1 but not of Th17 cells.
    Bing SJ; Lyu C; Xu B; Wandu WS; Hinshaw SJ; Furumoto Y; Caspi RR; Gadina M; Gery I
    Mol Vis; 2020; 26():641-651. PubMed ID: 33088168
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Preventive effect of chrysin on experimental autoimmune uveitis triggered by injection of human IRBP peptide 1-20 in mice.
    Meng X; Fang S; Zhang Z; Wang Y; You C; Zhang J; Yan H
    Cell Mol Immunol; 2017 Aug; 14(8):702-711. PubMed ID: 26996065
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The B subunit of Escherichia coli heat-labile enterotoxin inhibits Th1 but not Th17 cell responses in established experimental autoimmune uveoretinitis.
    Raveney BJ; Richards C; Aknin ML; Copland DA; Burton BR; Kerr E; Nicholson LB; Williams NA; Dick AD
    Invest Ophthalmol Vis Sci; 2008 Sep; 49(9):4008-17. PubMed ID: 18469197
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Total glucosides of paeony suppresses experimental autoimmune uveitis in association with inhibition of Th1 and Th2 cell function in mice.
    Huang XT; Wang B; Zhang WH; Peng MQ; Lin D
    Int J Immunopathol Pharmacol; 2018; 32():394632017751547. PubMed ID: 29363368
    [TBL] [Abstract][Full Text] [Related]  

  • 37. IFN-gamma-deficient mice develop experimental autoimmune uveitis in the context of a deviant effector response.
    Jones LS; Rizzo LV; Agarwal RK; Tarrant TK; Chan CC; Wiggert B; Caspi RR
    J Immunol; 1997 Jun; 158(12):5997-6005. PubMed ID: 9190954
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 4-Octyl Itaconate Inhibits Proinflammatory Cytokine Production in Behcet's Uveitis and Experimental Autoimmune Uveitis.
    Wang Q; Ye X; Tan S; Jiang Q; Su G; Pan S; Li H; Cao Q; Yang P
    Inflammation; 2024 Jun; 47(3):909-920. PubMed ID: 38183531
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Upregulated IL-21 and IL-21 receptor expression is involved in experimental autoimmune uveitis (EAU).
    Liu L; Xu Y; Wang J; Li H
    Mol Vis; 2009 Dec; 15():2938-44. PubMed ID: 20057909
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Experimental autoimmune uveoretinitis (EAU)-related tissue damage and angiogenesis is reduced in CCL2⁻/⁻CX₃CR1gfp/gfp mice.
    Zhao J; Chen M; Xu H
    Invest Ophthalmol Vis Sci; 2014 Oct; 55(11):7572-82. PubMed ID: 25342612
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.